Merck & Co., Inc. Release: ZOSTAVAX® (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that ZOSTAVAX® (Zoster Vaccine Live), the company’s vaccine to help prevent shingles, received the Prix Galien USA 2013 Award for Best Biotechnology Product.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC